Sudo Bio

Series-A
sudobio.com Biotech & Healthcare
Total Funding $37M
Latest Round $37M Series-A
Last Announced Sep 28, 2022
Investors Undisclosed
Decision Makers 5 Verified

About Sudo Bio

Sudo Biosciences develops first- and best-in-class medicines for serious neurological and immunological conditions like multiple sclerosis (MS) and other immune-mediated inflammatory conditions.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website sudobio.com
Domain Registered Date Mar 25, 2020

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $37,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    sudobio.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Sudo Bio.

Funding History

1 Round
Series-A · Sep 28, 2022

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts